These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33467190)

  • 1. Refinement of a Live Attenuated
    Nasrin S; Fuche FJ; Sears KT; Jones JA; Levine MM; Simon R; Tennant SM
    Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33467190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletions in
    Fuche FJ; Jones JA; Ramachandran G; Higginson EE; Simon R; Tennant SM
    Hum Vaccin Immunother; 2019; 15(6):1427-1435. PubMed ID: 29927725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and protective efficacy against
    Schuster O; Sears KT; Ramachandran G; Fuche FJ; Curtis B; Tennant SM; Simon R
    Hum Vaccin Immunother; 2019; 15(6):1436-1444. PubMed ID: 29873578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced immunogenicity of a live
    Allen JC; Toapanta FR; Baliban SM; Sztein MB; Tennant SM
    Front Immunol; 2023; 14():1190339. PubMed ID: 37207226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. O-Serotype Conversion in
    Li P; Liu Q; Luo H; Liang K; Yi J; Luo Y; Hu Y; Han Y; Kong Q
    Front Immunol; 2017; 8():1647. PubMed ID: 29255460
    [No Abstract]   [Full Text] [Related]  

  • 7. Refined live attenuated Salmonella enterica serovar Typhimurium and Enteritidis vaccines mediate homologous and heterologous serogroup protection in mice.
    Tennant SM; Schmidlein P; Simon R; Pasetti MF; Galen JE; Levine MM
    Infect Immun; 2015 Dec; 83(12):4504-12. PubMed ID: 26351285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An enterobacterial common antigen mutant of Salmonella enterica serovar Typhimurium as a vaccine candidate.
    Bridge DR; Whitmire JM; Gilbreath JJ; Metcalf ES; Merrell DS
    Int J Med Microbiol; 2015 Sep; 305(6):511-22. PubMed ID: 26070977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Three Candidate Live-Attenuated
    Sears KT; Nasrin S; Baliban SM; Council DN; Pasetti MF; Tennant SM
    Vaccines (Basel); 2023 Oct; 11(10):. PubMed ID: 37896965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and distribution of non-typhoidal
    Hagedoorn NN; Murthy S; Birkhold M; Marchello CS; Crump JA;
    Epidemiol Infect; 2023 Oct; 152():e4. PubMed ID: 37850326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of an attenuated Salmonella enterica serovar Paratyphi A vaccine candidate.
    Xiong K; Chen Z; Zhu C; Li J; Hu X; Rao X; Cong Y
    Int J Med Microbiol; 2015 Sep; 305(6):563-71. PubMed ID: 26239100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving Our Understanding of
    Higginson EE; Ramachandran G; Hazen TH; Kania DA; Rasko DA; Pasetti MF; Levine MM; Tennant SM
    mSphere; 2018 Nov; 3(6):. PubMed ID: 30487152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of an attenuated Salmonella enterica serovar Paratyphi A vaccine strain harboring defined mutations in htrA and yncD.
    Zhu C; Xiong K; Chen Z; Hu X; Li J; Wang Y; Rao X; Cong Y
    Microbiol Immunol; 2015 Aug; 59(8):443-51. PubMed ID: 26084199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salmonella Serogroup C: Current Status of Vaccines and Why They Are Needed.
    Fuche FJ; Sow O; Simon R; Tennant SM
    Clin Vaccine Immunol; 2016 Sep; 23(9):737-45. PubMed ID: 27413069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Highly Effective Component Vaccine against Nontyphoidal Salmonella enterica Infections.
    Ferreira RB; Valdez Y; Coombes BK; Sad S; Gouw JW; Brown EM; Li Y; Grassl GA; Antunes LC; Gill N; Truong M; Scholz R; Reynolds LA; Krishnan L; Zafer AA; Sal-Man N; Lowden MJ; Auweter SD; Foster LJ; Finlay BB
    mBio; 2015 Sep; 6(5):e01421-15. PubMed ID: 26396246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-protective immunity conferred by a DNA adenine methylase deficient Salmonella enterica serovar Typhimurium vaccine in calves challenged with Salmonella serovar Newport.
    Mohler VL; Heithoff DM; Mahan MJ; Walker KH; Hornitzky MA; Shum LW; Makin KJ; House JK
    Vaccine; 2008 Mar; 26(14):1751-8. PubMed ID: 18329764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontyphoidal salmonella disease: Current status of vaccine research and development.
    Tennant SM; MacLennan CA; Simon R; Martin LB; Khan MI
    Vaccine; 2016 Jun; 34(26):2907-2910. PubMed ID: 27032517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A bivalent vaccine derived from attenuated Salmonella expressing O-antigen polysaccharide provides protection against avian pathogenic Escherichia coli O1 and O2 infection.
    Han Y; Liu Q; Willias S; Liang K; Li P; Cheng A; Kong Q
    Vaccine; 2018 Feb; 36(8):1038-1046. PubMed ID: 29358057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactive immune response elicited by parenteral Vi polysaccharide typhoid vaccine against non-typhoid Salmonellae.
    Pakkanen SH; Kantele JM; Herzog C; Kantele A
    Vaccine; 2014 Jan; 32(5):544-51. PubMed ID: 24342246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.